Jubilant Ingrevia Limited
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing servic… Read more
Jubilant Ingrevia Limited (JUBLINGREA) - Net Assets
Latest net assets as of September 2025: ₹30.41 Billion INR
Based on the latest financial reports, Jubilant Ingrevia Limited (JUBLINGREA) has net assets worth ₹30.41 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹52.57 Billion) and total liabilities (₹22.16 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹30.41 Billion |
| % of Total Assets | 57.85% |
| Annual Growth Rate | N/A |
| 5-Year Change | 52.22% |
| 10-Year Change | N/A |
| Growth Volatility | 9.06 |
Jubilant Ingrevia Limited - Net Assets Trend (2020–2025)
This chart illustrates how Jubilant Ingrevia Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Jubilant Ingrevia Limited (2020–2025)
The table below shows the annual net assets of Jubilant Ingrevia Limited from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹29.27 Billion | +6.93% |
| 2024-03-31 | ₹27.37 Billion | +2.67% |
| 2023-03-31 | ₹26.66 Billion | +9.58% |
| 2022-03-31 | ₹24.33 Billion | +26.53% |
| 2021-03-31 | ₹19.23 Billion | +1662104.32% |
| 2020-03-31 | ₹-1.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Jubilant Ingrevia Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1432579700000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹14.32 Billion | 48.94% |
| Common Stock | ₹158.10 Million | 0.54% |
| Other Comprehensive Income | ₹9.61 Billion | 32.84% |
| Other Components | ₹5.18 Billion | 17.68% |
| Total Equity | ₹29.27 Billion | 100.00% |
Jubilant Ingrevia Limited Competitors by Market Cap
The table below lists competitors of Jubilant Ingrevia Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sino-High (China) Co. Ltd.
SHE:301076
|
$463.89 Million |
|
Jing Jin Electric Technologies Co Ltd
SHG:688280
|
$463.92 Million |
|
Kunming Yunnei Power Co Ltd
SHE:000903
|
$463.94 Million |
|
Shenzhen Qingyi Photomask Ltd
SHG:688138
|
$464.08 Million |
|
SP GROUP AS NAM. DK 2
F:1PU2
|
$463.76 Million |
|
Century Plyboards (India) Limited
NSE:CENTURYPLY
|
$463.69 Million |
|
Quick Intelligent Equipment Co Ltd
SHG:603203
|
$463.63 Million |
|
Atom Hoteles Socimi
MC:YATO
|
$463.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jubilant Ingrevia Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 27,374,740,000 to 29,270,800,000, a change of 1,896,060,000 (6.9%).
- Net income of 2,511,700,000 contributed positively to equity growth.
- Dividend payments of 797,700,000 reduced retained earnings.
- Share repurchases of 43,800,000 reduced equity.
- New share issuances of 43,800,000 increased equity.
- Other comprehensive income increased equity by 117,140,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹2.51 Billion | +8.58% |
| Dividends Paid | ₹797.70 Million | -2.73% |
| Share Repurchases | ₹43.80 Million | -0.15% |
| Share Issuances | ₹43.80 Million | +0.15% |
| Other Comprehensive Income | ₹117.14 Million | +0.4% |
| Other Changes | ₹64.92 Million | +0.22% |
| Total Change | ₹- | 6.93% |
Book Value vs Market Value Analysis
This analysis compares Jubilant Ingrevia Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.06x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | ₹-0.01 | ₹564.65 | x |
| 2021-03-31 | ₹120.91 | ₹564.65 | x |
| 2022-03-31 | ₹152.97 | ₹564.65 | x |
| 2023-03-31 | ₹167.67 | ₹564.65 | x |
| 2024-03-31 | ₹172.82 | ₹564.65 | x |
| 2025-03-31 | ₹184.60 | ₹564.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jubilant Ingrevia Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.58%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.01%
- • Asset Turnover: 0.83x
- • Equity Multiplier: 1.72x
- Recent ROE (8.58%) is above the historical average (8.20%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -0.02% | 13579.38x | 0.00x | ₹-1.54 Million |
| 2021 | 2.83% | 7.95% | 0.20x | 1.76x | ₹-1.38 Billion |
| 2022 | 19.59% | 9.63% | 1.30x | 1.56x | ₹2.33 Billion |
| 2023 | 11.53% | 6.44% | 1.12x | 1.60x | ₹408.77 Million |
| 2024 | 6.68% | 4.42% | 0.87x | 1.73x | ₹-908.59 Million |
| 2025 | 8.58% | 6.01% | 0.83x | 1.72x | ₹-415.38 Million |
Industry Comparison
This section compares Jubilant Ingrevia Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $2,571,777,102
- Average return on equity (ROE) among peers: 15.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jubilant Ingrevia Limited (JUBLINGREA) | ₹30.41 Billion | 0.00% | 0.73x | $463.89 Million |
| Aarti Industries Limited (AARTIIND) | $8.75 Billion | 18.56% | 2.05x | $1.01 Billion |
| Aarti Surfactants Limited (AARTISURF) | $2.18 Billion | 9.78% | 0.94x | $15.14 Million |
| ABM International Limited (ABMINTLLTD) | $214.51 Million | 3.09% | 0.89x | $294.24K |
| ACUTAAS CHEMICALS LTD (ACUTAAS) | $5.94 Billion | 14.02% | 0.29x | $247.08K |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $984.09 Million | 34.30% | 2.55x | $95.16 Million |
| Agarwal Industrial Corporation Limited (AGARIND) | $739.40 Million | 9.29% | 0.98x | $26.89 Million |
| Alkali Metals Limited (ALKALI) | $513.80 Million | 2.54% | 0.73x | $1.88 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $3.79 Billion | 22.71% | 1.01x | $204.91 Million |
| Ami Organics Limited (AMIORG) | $107.73 Million | 26.58% | 2.59x | $704.27 Million |
| Anupam Rasayan India Limited (ANURAS) | $2.50 Billion | 13.94% | 1.53x | $318.75 Million |